Back to Search Start Over

Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil.

Authors :
Faria NR
Mellan TA
Whittaker C
Claro IM
Candido DDS
Mishra S
Crispim MAE
Sales FC
Hawryluk I
McCrone JT
Hulswit RJG
Franco LAM
Ramundo MS
de Jesus JG
Andrade PS
Coletti TM
Ferreira GM
Silva CAM
Manuli ER
Pereira RHM
Peixoto PS
Kraemer MU
Gaburo N Jr
Camilo CDC
Hoeltgebaum H
Souza WM
Rocha EC
de Souza LM
de Pinho MC
Araujo LJT
Malta FSV
de Lima AB
Silva JDP
Zauli DAG
de S Ferreira AC
Schnekenberg RP
Laydon DJ
Walker PGT
Schlüter HM
Dos Santos ALP
Vidal MS
Del Caro VS
Filho RMF
Dos Santos HM
Aguiar RS
Modena JLP
Nelson B
Hay JA
Monod M
Miscouridou X
Coupland H
Sonabend R
Vollmer M
Gandy A
Suchard MA
Bowden TA
Pond SLK
Wu CH
Ratmann O
Ferguson NM
Dye C
Loman NJ
Lemey P
Rambaut A
Fraiji NA
Carvalho MDPSS
Pybus OG
Flaxman S
Bhatt S
Sabino EC
Source :
MedRxiv : the preprint server for health sciences [medRxiv] 2021 Mar 03. Date of Electronic Publication: 2021 Mar 03.
Publication Year :
2021

Abstract

Cases of SARS-CoV-2 infection in Manaus, Brazil, resurged in late 2020, despite high levels of previous infection there. Through genome sequencing of viruses sampled in Manaus between November 2020 and January 2021, we identified the emergence and circulation of a novel SARS-CoV-2 variant of concern, lineage P.1, that acquired 17 mutations, including a trio in the spike protein (K417T, E484K and N501Y) associated with increased binding to the human ACE2 receptor. Molecular clock analysis shows that P.1 emergence occurred around early November 2020 and was preceded by a period of faster molecular evolution. Using a two-category dynamical model that integrates genomic and mortality data, we estimate that P.1 may be 1.4-2.2 times more transmissible and 25-61% more likely to evade protective immunity elicited by previous infection with non-P.1 lineages. Enhanced global genomic surveillance of variants of concern, which may exhibit increased transmissibility and/or immune evasion, is critical to accelerate pandemic responsiveness.<br />Competing Interests: Competing interests: Authors declare that they have no competing interests.

Details

Language :
English
Database :
MEDLINE
Journal :
MedRxiv : the preprint server for health sciences
Accession number :
33688664
Full Text :
https://doi.org/10.1101/2021.02.26.21252554